Following the first report of COVID-19 infection in December 2019 as a respiratory illness, it has proven to be a multisystem disease. There are few reported cases of ischemic colitis with COVID-19 infection in the medical literature to date and we have limited understanding of its pathophysiology. We report 2 cases of ischemic colitis as the only manifestation of COVID-19. In addition, we review the current limited literature regarding COVID-19-associated ischemic colitis.

Table 1. ERCP Results ERCP without Rigidizing Overtube ERCP with Rigidizing Overtube Technical Success, n (%) 74/91 (81.0%) 10/11 (90.9%) Clinical Success, n (%) 57/85 (76.2%) 10/10** (100.0%) Adverse Events, n (%) 5/91 (6.0%) 0/11 (0.0%) Post-procedure Fever, n (%) 4/5 (80.0%) -Cholangitis, n (%) 1/5 (20.0%) -**No follow-up data available for 1 case.

No abstract

No abstract